{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:22:34Z","timestamp":1783549354432,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.diabres.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T02:41:11Z","timestamp":1334112071000},"page":"438-445","source":"Crossref","is-referenced-by-count":36,"title":["A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: Efficacy and tolerability in a double-blind, randomized, controlled clinical trial"],"prefix":"10.1016","volume":"97","author":[{"given":"David","family":"Sandercock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilou","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Biton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verne E.","family":"Cowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2012.03.010_bib0005","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/dmrr.361","article-title":"Treatment of symptomatic diabetic neuropathy","volume":"19","author":"Boulton","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2012.03.010_bib0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11916-003-0070-9","article-title":"Pharmacotherapy of painful diabetic neuropathy","volume":"7","author":"Barbano","year":"2003","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.diabres.2012.03.010_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.46.1.267","article-title":"Diabetes control and complications","volume":"46","author":"Crofford","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.diabres.2012.03.010_bib0020","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4065\/79.12.1533","article-title":"Contemporary management of neuropathic pain for the primary care physician","volume":"79","author":"Chen","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.diabres.2012.03.010_bib0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.diabres.2012.03.010_bib0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pmrj.2011.03.008","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"3","author":"Bril","year":"2011","journal-title":"PM R"},{"key":"10.1016\/j.diabres.2012.03.010_bib0035","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2012.03.010_bib0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabres.2012.03.010_bib0045","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.diabres.2012.03.010_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.diabres.2012.03.010_bib0055","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.diabres.2012.03.010_bib0060","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/diacare.29.04.06.dc05-1967","article-title":"Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes","volume":"29","author":"Schwartz","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2012.03.010_bib0065","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1128\/AAC.49.10.4137-4143.2005","article-title":"Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women","volume":"49","author":"Fourcroy","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabres.2012.03.010_bib0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1023\/A:1018951214146","article-title":"A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma","volume":"10","author":"Stewart","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.diabres.2012.03.010_bib0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0091270010368411","article-title":"Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and the effect of dose escalation and food","volume":"51","author":"Chen","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.diabres.2012.03.010_bib0080","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.clinthera.2008.05.008","volume":"30","author":"Gordi","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabres.2012.03.010_bib0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.diabres.2012.03.010_bib0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0733-8619(05)70097-9","article-title":"Pain assessment and evaluation of patients who have neuropathic pain","volume":"16","author":"Backonja","year":"1998","journal-title":"Neurol Clin"},{"key":"10.1016\/j.diabres.2012.03.010_bib0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/AJP.0b013e3181934276","article-title":"Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial","volume":"25","author":"Irving","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.diabres.2012.03.010_bib0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11539520-000000000-00000","article-title":"Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study","volume":"30","author":"Wallace","year":"2010","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.diabres.2012.03.010_bib0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3810\/pgm.1999.11.770","article-title":"Following the clues to neuropathic pain. Distribution and other leads reveal the cause and the treatment approach","volume":"106","author":"Belgrade","year":"1999","journal-title":"Postgrad Med"},{"key":"10.1016\/j.diabres.2012.03.010_bib0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pain.2005.10.007","article-title":"Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy","volume":"120","author":"Odrcich","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.diabres.2012.03.010_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0304-3959(95)00214-6","article-title":"Gender variations in clinical pain experience","volume":"65","author":"Unruh","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.diabres.2012.03.010_bib0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.pain.2004.03.028","article-title":"Gender differences in pain, coping, and mood in individuals having osteoarthritic knee pain: a within-day analysis","volume":"110","author":"Keefe","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.diabres.2012.03.010_bib0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1054-139X(94)90628-9","article-title":"Gender differences in human pharmacokinetics and pharmacodynamics","volume":"15","author":"Fletcher","year":"1994","journal-title":"J Adolesc Health"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822712001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822712001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T01:23:01Z","timestamp":1543022581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822712001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0168822712001222"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2012.03.010","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}